Wed.Jul 19, 2023

article thumbnail

Wilson Bryan, former FDA gene therapy leader, joins consulting firm

Bio Pharma Dive

The agency veteran, who led the Office of Tissues and Advanced Therapies during a boom in gene and cell therapy research, retired in March.

article thumbnail

Twist and Cancer Research Horizons sign antibody library platform deal

Pharmaceutical Technology

Twist Bioscience and CRUK innovation arm Cancer Research Horizons have signed an agreement for licensing a library of libraries.

Antibody 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Indian pharma market will touch US$ 130 billion by 2030: Dr S V Veeramani

AuroBlog - Aurous Healthcare Clinical Trials blog

India’s pharmaceutical market is growing at a healthy rate and is expected to touch 130 billion USD by 2030, said Dr. SV Veeramani, chairman of the Pharmaceuticals Export Promotion Council of India (Pharmexcil) while delivering the keynote address at the Pharmac South Expo 2023 in Chennai on July 14.

Marketing 151
article thumbnail

US DoD enlists VitriVax to develop one-shot vaccine for melioidosis

Pharmaceutical Technology

B. pseudomallei is resistant to many antibiotics and, without treatment, can be lethal to those infected.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

J&J joins pharma allies in challenging US drug pricing law

Bio Pharma Dive

The pharma claimed in federal court that the Inflation Reduction Act, which threatens sales of its blood thinner Xarelto, amounts to “confiscation of constitutionally protected property.

Sales 130
article thumbnail

July 19, 2023: IMPACt-LBP Study Team Will Share Early Lessons in This Friday’s PCT Grand Rounds

Rethinking Clinical Trials

From left: Dr. Christine Goertz and Dr. Adam Goode of the IMPACt-LBP Demonstration Project In this Friday’s PCT Grand Rounds, Dr. Christine Goertz and Dr. Adam Goode of Duke University will present “Implementing New Care Pathways for Low Back Pain in Academic Healthcare Systems: Early Lessons From IMPACt-LBP.” The Grand Rounds session will be held on Friday, July 21, 2023, at 1:00 pm eastern.

More Trending

article thumbnail

Argenx raises $1.1B on heels of rare disease drug data

Bio Pharma Dive

The follow-on stock offering is particularly large for a biotechnology company and will bolster the financial position of Argenx, now worth nearly $30 billion.

Drugs 130
article thumbnail

Amarin restructures to counter downturn following Vascepa generics

Pharmaceutical Technology

Amarin Corporation has initiated a company restructuring programme, following a business review by its new board and senior management team.

130
130
article thumbnail

Amarin, Fibrogen lay off staff as biotech cost cutting continues

Bio Pharma Dive

The two drugmakers moved to trim costs following clinical and commercial setbacks, joining a lengthening list of biotechs forced into similar restructurings.

130
130
article thumbnail

Pieris Pharma lays off 70% of workforce amid company restructuring

Pharmaceutical Technology

The biotech announced its employee cuts as part of a strategic update partly caused by the termination of its AstraZeneca collaboration.

130
130
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Podcast July 7, 2023: BeatPain Utah: Partnering with Community Health Centers Within a Socio-Technical Framework (Julie Fritz, PhD, PT)

Rethinking Clinical Trials

This podcast continues the discussion with Dr. Julie Fritz as she discusses partnering with community health centers within a socio-technical framework through BeatPain Utah. Click on the recording below to listen to the podcast.  NIH Pragmatic Trials Collaboratory · Podcast 45: From Observational Studies to Pragmatic Clinical Trials: Research in PCORnet® NIH Pragmatic Trials Collaboratory · Podcast 44: The Heartline Trial: A New Paradigm in Conducting Virtual Clinical Trials NIH Pragmatic Tria

article thumbnail

Advent receives US NIH grant for bronchopulmonary dysplasia therapy

Pharmaceutical Technology

Advent Therapeutics has received a grant worth $3m from the US NIH for expediting the development of bronchopulmonary dysplasia therapy.

article thumbnail

Grand Rounds July 14, 2023: Lessons From the COORDINATE-Diabetes Trial (Christopher B. Granger, MD; Neha J. Pagidipati, MD, MPH)

Rethinking Clinical Trials

    Speaker Christopher B. Granger, MD Donald F. Fortin, M.D. Distinguished Professor of Medicine Professor of Nursing Duke University Neha J. Pagidipati, MD MPH Associate Professor of Medicine, Duke University School of Medicine Slides Keywords COORDINATE-Diabetes; Cardiovascular disease; Intervention; Cluster-randomized trial; Implementation; Prescription Key Points High-intensity statins, ACEi/ARBs, and SGLT2i and GLP-1RA have been shown to improve recovery and maintenance outcomes for pa

Trials 130
article thumbnail

Novartis reports 7% rise in Q2 2023 net sales

Pharmaceutical Technology

Novartis has reported net sales of $13.62bn in Q2 of 2023, indicating a 7% rise compared to $12.78bn in the same quarter of 2022.

Sales 130
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Engaging Communities through High-Impact Healthcare Sponsorships in the Pharmaceutical Industry 

Pharma Marketing Network

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s

article thumbnail

Telix adds another trial in its targeted radiation therapy development programme

Pharmaceutical Technology

The Phase I trial evaluates the combination Telix’s targeted radiation therapy with Merck’s peposertib, a DNA-PK Inhibitor.

Trials 130
article thumbnail

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry

Pharma Marketing Network

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. By creating and distributing valuable content, businesses can attract and engage their target audience, position themselves as experts in their field, and build trust with potential customers.

Sales 98
article thumbnail

Santhera and Catalyst to market DMD drug vamorolone in North America

Pharmaceutical Technology

The agreement covers licensing rights in North America for Duchenne muscular dystrophy and other future indications.

Licensing 130
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Creating Synergy: Aligning Brand Values with High-Impact Healthcare Sponsorships in the Pharmaceutical Industry 

Pharma Marketing Network

Sponsorships can be a powerful way for businesses to connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But in order to be truly effective, sponsorships must be aligned with a company’s brand values. For pharmaceutical companies, this means aligning sponsorships with causes that are related to health and wellness.

article thumbnail

Flagship Pioneering collaborates with Pfizer to develop new therapies

Pharmaceutical Technology

Flagship Pioneering has entered into a collaboration with Pfizer to develop a new innovative therapy pipeline.

article thumbnail

Kaiser Permanente Strike Looms as Union Workers Ramp Up Pressure

XTalks

As the pressure builds on Kaiser Permanente, an 85,000-member strong unionized healthcare workforce is upping the ante in the negotiation of a new labor contract. The Coalition of Kaiser Permanente Unions announced this week that its members will stage pickets at 50 Kaiser Permanente facilities spread across California, Washington, Oregon and Colorado, sparking fears of a Kaiser Permanente strike.

article thumbnail

Choosing the Right Sponsorships for Maximum Impact in the Pharmaceutical Industry 

Pharma Marketing Network

Sponsorships can be a powerful tool for pharmaceutical companies to engage with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But with so many different healthcare organizations and causes to choose from, it can be difficult to know where to start. Here are some tips for choosing the right sponsorships for maximum impact in the pharmaceutical industry: Start with your goals: What do you hope to achieve through your sponsorship?

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Obesity drug shortage expands to Saxenda as Novo Nordisk warns of limited supply for 2023 and beyond

Fierce Pharma

After Novo Nordisk's popular obesity medicine Wegovy went into short supply, people turned to the company first-generation weight-loss drug, Saxenda, for treatment. | After Novo Nordisk's Wegovy became hard to come by, people turned to the company first-generation weight loss drug, Saxenda, for treatment. Now, the company is struggling to handle demand for that product.

Drugs 96
article thumbnail

Digital Disruption in Pharma: Harnessing Technology for Effective Marketing Campaigns 

Pharma Marketing Network

The pharmaceutical industry is constantly evolving, and digital technology is playing an increasingly important role in marketing campaigns. In the past, pharmaceutical companies relied heavily on traditional marketing methods such as print ads, TV commercials, and direct mail. However, these methods are becoming less effective as consumers are increasingly turning to digital channels for information and research.

article thumbnail

Women in Science: Inato's Liz Beatty and her aim to combat underrepresentation in clinical trials

BioPharma Reporter

Liz Beatty is co-founder and chief strategy officer at Inato, a clinical trials platform which flips the traditional model and allows community sites to participate in the trials that are best aligned with their interests and that of their patients.

article thumbnail

Members of the Alliance for Genomic Discovery revealed

Pharma Times

Illumina and Nashville Biosciences’ have announced AbbVie, Amgen, AstraZeneca, Bayer and Merck as founding members - News - PharmaTimes

Genome 98
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

GSK-funded report on adult vaccination rates ?finds major global declines in recent years

Fierce Pharma

While vaccines for COVID-19 have certainly enjoyed the spotlight in recent years, rates of uptake for other shots have sharply declined. | The GSK-funded report looked at adult vaccination data and found a major slump in vaccine adoption over the last few years, save for COVID vaccines.

article thumbnail

Glaucoma therapy Roclanda launched by Santen

Pharma Times

By combining both netarsudil and latanoprost treatment, Roclanda reduces intraocular pressure - News - PharmaTimes

95
article thumbnail

Argenx raises $1.1B through global stock placement after Vyvgart's CIDP trial win

Fierce Pharma

Right on the heels of a major study win for its star drug Vyvgart, argenx has raised more than $1 billion in cash to support its operations. | Right on the heels of a major study win for its star drug Vyvgart, argenx has raised more than $1 billion in cash to support its operations.

Trials 82
article thumbnail

Pharmacovigilance in Clinical Trials: Safeguarding Participant Safety and Ensuring Data Integrity

Cloudbyz

Clinical trials are vital in advancing medical knowledge and developing new treatments. However, ensuring participant safety is paramount throughout the trial process. Pharmacovigilance plays a critical role in monitoring adverse events, collecting safety data, and reporting requirements to protect participants. This blog delves into the significance of pharmacovigilance in clinical trials, highlighting its role in participant safety, data integrity, and regulatory compliance.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.